ArticleEClinicalMedicine2025

Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial.

Arndt Stahler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.